Ouvrages publiés en collaboration (2)
  1. 1. Rosiere, R., Amighi, K., & Wauthoz, N. (2019). Nanotechnology-based targeted drug delivery systems for lung cancer: Nanomedicine-based inhalation treatments for lung cancer.
  2. 2. Wauthoz, N., & Amighi, K. (2015). Pulmonary drug delivery : Advances and Challenges: Formulation strategies for pulmonary drug delivery of poorly soluble drugs. Wiley.
    3.   Parties d'ouvrages collectifs (1)
  3. 1. Wauthoz, N., & Amighi, K. (2015). Formulation strategies for pulmonary delivery of poorly soluble drugs. In Pulmonary Drug Delivery: Advances and Challenges (pp. 87-121). wiley. doi:10.1002/9781118799536.ch5
    4.   Articles dans des revues avec comité de lecture (126)
  4. 1. Davenne, T., Percier, P., Larbanoix, L., Moser, M., Leo, O., Meylan, E., Goriely, S., Gérard, P., Wauthoz, N., Laurent, S., Amighi, K., & Rosiere, R. (2022). Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model. Journal of controlled release, 353, 317-326. doi:10.1016/j.jconrel.2022.11.055
  5. 2. Menchi, E., El Khattabi, C., Pochet, S., Denis, O., Amighi, K., & Wauthoz, N. (2022). Optimization of Long-Acting Bronchodilator Dose Ratios Using Isolated Guinea Pig Tracheal Rings for Synergistic Combination Therapy in Asthma and COPD. Pharmaceuticals, 15(8). doi:https://doi.org/10.3390/ ph15080963
  6. 3. Gevenois, P., De Pauw, P., Schoonooghe, S., Delporte, C., Sebti, T., Amighi, K., Muyldermans, S., & Wauthoz, N. (2021). Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead Optimization. Journal of immunology (Baltimore, Md. : 1950), 207(10), 2608-2620. doi:10.4049/jimmunol.2100250
  7. 4. Tabare, E., Glonti, T., Cochez, C., Ngassam, C., Pirnay, J.-P., Amighi, K., & Goole, J. (2021). A Design of Experiment Approach to Optimize Spray-Dried Powders Containing Pseudomonas aeruginosa Podoviridae and Myoviridae Bacteriophages. Viruses, 13(10), 1926. doi:10.3390/v13101926
  8. 5. Chraibi, S., Rosiere, R., De Prez, E., Gérard, P., Antoine, M.-H., Langer, I., Nortier, J., Remmelink, M., Amighi, K., & Wauthoz, N. (2021). Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer. Biomedicine & pharmacotherapy, 139, 111716. doi:10.1016/j.biopha.2021.111716
  9. 6. Chraibi, S., Rosiere, R., Larbanoix, L., Gérard, P., Hennia, I., Laurent, S., Vermeersch, M., Amighi, K., & Wauthoz, N. (2021). The combination of an innovative dry powder for inhalation and a standard cisplatin-based chemotherapy in view of therapeutic intensification against lung tumours. European journal of pharmaceutics and biopharmaceutics, 164, 93-104. doi:10.1016/j.ejpb.2021.04.018
  10. 7. Koubaity, M., Lechon, A.-S., Amighi, K., Van Nuffelen, M., Moreau, M., Meert, A.-P., & De Vriese, C. (2021). Drug-related problems and risk factors related to unplanned hospital readmission among cancer patients in Belgium. Supportive care in cancer. doi:10.1007/s00520-020-05916-w
  11. 8. Chraibi, S., Rosiere, R., De Prez, E., Antoine, M.-H., Remmelink, M., Langer, I., Nortier, J., Amighi, K., & Wauthoz, N. (2021). Pulmonary and renal tolerance of cisplatin-based regimens combining intravenous and endotracheal routes for lung cancer treatment in mice. International journal of pharmaceutics, 599, 120425. doi:10.1016/j.ijpharm.2021.120425
  12. 9. Carlier, E., Marquette, S., Peerboom, C., Amighi, K., & Goole, J. (2021). Development of mAb-loaded 3D-printed (FDM) implantable devices based on PLGA. International journal of pharmaceutics, 597, 120337. doi:10.1016/j.ijpharm.2021.120337
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Suivant >>